期刊文献+

老年黄斑变性高危患者预防性治疗的临床应用 被引量:4

Clinical Application of Prophylactic Treatment for High Risk Patients With Age-related Macular Degeneration
下载PDF
导出
摘要 目的对老年黄斑变性高危患者的临床预防性治疗进行研究分析,探讨其作用,为降低患者该疾病的发生率,预防失明提供参考。方法选取我院的120例黄斑变性高危老年患者来进行研究分析,使用预防性治疗,对患者提供抗衰老药物和调整微循环药物,对患者的治疗情况进行研究分析。结果全部患者有80%其视力能够维持现状或者有所改善,有10%患者出现了视力衰退的症状,5%患者有黄斑变性,5%不能够坚持完成治疗,视力衰退。结论黄斑变性高危患者使用抗衰老、调整微循环、营养素等治疗,可以让患者的视力得到较大的改善,黄斑变性几率降低,患者的生活品质有所保障。 Objective Research on the clinical preventive treatment for elderly patients at high risk of macular degeneration. To reduce the incidence of patients with the disease. Methods Chose 120 cases of macular degeneration in elderly high-risk patients in our hospital to carry out research and analysis,we used prophylactic treatment of patients with anti-aging drugs and medication adjustments microcirculation. Results 80% patients maintained the status quo or improved,10% patients with symptoms of vision loss,5% patients with macular degeneration,5% not able to adhere to the completion of treatment,and had vision loss. Conclusion High risk patients of macular degeneration using anti-aging,adjust the microcirculation,nutrients and other treatment,the patient's vision can be greatly improved,reducing the chance of macular degeneration,the patient's quality of life is guaranteed.
作者 张云贵
出处 《中国卫生标准管理》 2015年第16期48-49,共2页 China Health Standard Management
关键词 黄斑变性 高危患者 预防 Macular degeneration High-risk patients Prevention
  • 相关文献

参考文献3

二级参考文献9

  • 1邹海东,张晳,许迅,汪枫桦,张世杰.上海市静安区曹家渡街道年龄相关性黄斑变性的患病率调查[J].中华眼科杂志,2005,4(1):15-19. 被引量:107
  • 2RamaDJager, WilliamF.Mieler,andJoanW.MillerAge-RelatedMacularDegeneration.NEnglJMed, 2008,358 : 2606-2617.
  • 3Klein R, Klein BE, Tomany SC, et al.Ten-year incidence of age-related maculopathy and smoking and drinking:The Beaver Dam Eye study. Am J Epidemiol, 2002, 156: 589-598.
  • 4Khan JC, Thurlby DA, Shahid H, Clayton DG, Yates JR, Bradley M, et al.Smoking and age related macular degeneration:the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation.Br J Ophthalmol, 2006,90( 1 ) : 75-80.
  • 5Tomany SC, Cruickshanks K J, Klein R, et al.Sunlight and the 10-year incidence of age-related maculopsthy:the Beaver Dam Eye Study.Arch Opthalmol, 2004,122 : 750-757.
  • 6Klein R, klein BE, Tomany SC, et al.Age-related maculopsthy and sun exposure,iris colour,and skin sensitivity to sunlight.Br Ophthalmol, 2006,90: 29-32.
  • 7KasaharaE, LinLR, HoYS, etal.SOD2 protect against oxidation-induced apoptosis in mouse retinal pigment epithelium: implications for age-related macular degeneration.Invest Ophthalmol Vis Sci, 2005,46 (9) : 3426-3434.
  • 8Arandomized,placebo-control,clinicaltrialofhigh-dosesupplementation- withVitaminCandE, beta Carotene,andzincfor age-related macular degenerationandvisionloss.AREDSreportno.8.Archophthalmol,2001,119 ( 10): 1417-1436.
  • 9San Giovanni JP,Chen EY,Clemons TE,et al.The relationship of dietary lipid intake and age-related macular degeneration in a case-control study : AREDS Report No.20.Arch Opthalmol, 2007,125 (5):671-679.

共引文献7

同被引文献20

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部